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David B. Nash: The Bleeding Edge

From the Editor
The Bleeding Edge
Almost four years ago, I was intrigued by a very incisive and provocative editorial1 in
the Wall Street Journal by J. D. Kleinke, a noted healthcare economist. The editorial
spoke of an industrial revolution coming to medicine based on a rationalization of the
haphazard use of services, an improvement in quality, and a reduction in costs. Now,
the same author has written a new book entitled, The Bleeding Edge,2 published
recently by Aspen Publishers. I thought our readership would be interested in his
detailed thesis about the future, focused on the ascendancy of a new business entity
in health care, the EHO—the Emerging Healthcare Organization.
The central thesis of this fascinating book is that five key forces will culminate in the
transformation of the health care industry to a world of EHOs characterized by
decreased costs, an increase in quality, and the "liberation" of physicians from the
perceived bonds of managed care. Let me first note these five forces and define
them; then, we will explore Kleinke’s vision for each of these forces in turn. The key
question that Kleinke addresses is, "How do we transform 15% of the world’s largest
economy?" The interaction among these five forces provides the driving energy for
the transformation. The five forces include risk assumption, consumerism,
consolidation, integration, and ultimately industrialization. These five forces will
create a post-managed care organization world with the inevitable demise of the
national managed care companies that we know today. The managed care company
of the future will become only a middle-market health plan reduced to sales,
marketing, and reinsurance functions only. Over time, according to Kleinke, EHOs
will eventually "develop the critical mass and organization sophistication necessary to
assume financial risk, thereby industrializing their processes of care to manage this
risk in a profitable way" in a nutshell, a complete transformation of the healthcare
economy. Let’s review these five forces in turn.
Risk assumption will correct the fundamental problems in healthcare consumption
and market economics. Kleinke contends that through risk assumption or capitation
physicians and hospitals will be required to act like all other free-market producers of
goods who are motivated to focus not only on maximizing revenues but also on the
cost of the goods sold. He specifically contends that capitation will force us to
confront the reality that physicians are self-interested economic agents—surely, a
provocative viewpoint. Capitation, then, becomes the vehicle for "provider liberation"
by eliminating the middleman and guaranteeing provider ascendancy in this New
World Order of the EHO. As the role of the managed care organization becomes
increasingly marginalized, one simple truth emerges in Kleinke’s vision that "in the
new century’s healthcare system, the only transactions left will be the transfer and
assumption of medical/financial risk."
The second force, consumerism, will neutralize distortions in the healthcare system
created by the self-interest and faulty paternalism of managed care organizations
and other insurers. Consumerism will correct the "asymmetries of information" by
providing consumers with information for more informed decision-making. It will also
engender the branding of healthcare services. Both topics have been covered in this
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column previously ("Consumerism in Health Care," September 1998 [Vol. 11, No.
3]).
The third force, consolidation, will rescale the healthcare infrastructure properly,
mobilize capital, spread risk across broader populations of patients and providers,
and allocate healthcare resources more efficiently. Essentially, this section of the
book repeats his key theme that healthcare is transforming itself into a business, no
less exempt from the laws of competition than automobiles or the airline industry.
Why are managed care organizations like Aetna U.S. Healthcare purchasing
Prudential and NYLCare? According to Kleinke, its nothing but the law of large
numbers. They are attempting to create larger risk pools to better absorb larger
losses. Bigger is less risky. But Kleinke contends that this is their "only structural
competitive advantage" against the fundamental economic challenge posed by what
he calls "forward integration of providers." Translation: the managed care companies
can get bigger and bigger but, eventually, the elimination of the middleman will
occur if providers are able to integrate and industrialize their processes.
Integration, the fourth force, corrects the fragmentation and other structural defects
built into the medical delivery system. Kleinke calls this the end of "clinical
apartheid"—meaning that those decisions with the greatest impact on the
institution’s cost and profits, and the quality of the care delivered, are made by a
class of people not usually employed by that institution. Of course, he speaks here of
physicians. Integration and integrated delivery systems are, themselves, better able
to systematically study how to improve the process of care. As provider information
systems mature and go beyond simple intermediate measures, like length-of-stay
and the cost of prescriptions, we will enter the integration stage where the true
endpoints for measurement, like total costs and final outcomes (across the
continuum of care), will be quantifiable. Integration, then, becomes inextricably
linked to quality improvement, better information systems, better understanding of
the processes, and improved ability to change those processes. Simply put,
integration is the gateway to the final force of industrialization.
The fifth force, industrialization, according to Kleinke, is the stage where we
rationalize the haphazard use of services, increase economic predictability, improve
quality, and reduce costs. This might sound familiar to our newsletter readers
("Higher Quality at Lower Cost?" January 1999 [Vol. 12, No. 1]). Industrialization
means that providers will bring to an end unexplained clinical variation and
neutralize unnecessary heterogeneity in the processes we use to care for patients.
The richness of the clinical data available to us will become our critical strategic
advantage for the future, eclipsing the claims-based data left available to the
insuring organizations. Finally, we will obtain the greatest paradox of all, according
to Kleinke, in that "physicians will be driven by their own financial self-interest to
create and support systems that measure their own performance, reduce variability,
and promote treatment paths where they, themselves, are the providers of last
resort."
Certainly, this book may not appeal to everyone. Yet the theme, as articulated
through these five forces, is an engaging hypothesis worthy of our discussion and
debate. Kleinke has asked some critical questions and put forward his own wellsupported views about the transformation of the business of healthcare into the next
century. Perhaps he will begin a more focused national provider-driven debate on
these salient issues. Selfishly, I would like to continue the discussion and I am, as
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usual, interested in your views. Kleinke can be reached directly at his Web Site:
http://www.hs-net.com.
-

David B. Nash, MD, MBA
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